seed
Stage
About
Illuminare is a clinical-stage biotechnology company developing a small molecule fluorescent agent, Illuminare-1, for real-time intraoperative visualization of peripheral nerves to reduce nerve damage during surgery.
Explore Illuminare's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.